2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q3 2023. The put-call ratio across all filers is 3.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,259 | -59.8% | 25,066 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $244,651 | +32.9% | 24,175 | +34.0% | 0.00% | 0.0% |
| Q1 2023 | $184,059 | +11.1% | 18,045 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $165,708 | -35.8% | 17,685 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $258,000 | +11.7% | 17,749 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $231,000 | +16.7% | 17,499 | +50.6% | 0.00% | +100.0% |
| Q1 2022 | $198,000 | -35.5% | 11,618 | -2.9% | 0.00% | -50.0% |
| Q4 2021 | $307,000 | – | 11,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
| Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
| Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
| EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
| Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
| Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
| CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
| Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |